CSP-1 的特性研究，一种新型的可扩展谱β-内酰胺酶，由临床分离的 Capnocytophaga sputigena 产生。
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
机构信息
Service de Bactériologie, Centre Hospitalo-Universitaire d'Amiens, Hôpital Nord, Faculté de Médecine d'Amiens, Université de Picardie Jules Verne, Amiens, France.
出版信息
Antimicrob Agents Chemother. 2010 May;54(5):2231-4. doi: 10.1128/AAC.00791-09. Epub 2010 Mar 22.
Abstract
The Capnocytophaga sputigena isolate NOR, responsible for septicemia, was resistant to amoxicillin and narrow-spectrum cephalosporins. In a cloning experiment, a new gene, bla(CSP-1), was identified; this gene encodes a novel extended-spectrum beta-lactamase (ESBL) that shares only 52% and 49% identities with the CME-1 and VEB-1 beta-lactamases, respectively. The G+C content of this gene, its genetic environment, the absence of conjugation transfer, and its detection in two reference strains suggested that it was an intrinsic resistance gene located on the chromosome.
摘要
分离自导致败血症的斯氏片球菌（Capnocytophaga sputigena）的 NOR 株对阿莫西林和窄谱头孢菌素具有耐药性。在克隆实验中，鉴定出一个新基因 bla(CSP-1)，该基因编码一种新型的超广谱β-内酰胺酶（ESBL），与 CME-1 和 VEB-1 内酰胺酶的分别只有 52%和 49%的同源性。该基因的 G+C 含量、遗传环境、缺乏接合转移以及在两个参考菌株中的检出提示其是位于染色体上的固有耐药基因。
相似文献
1
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Antimicrob Agents Chemother. 2010 May;54(5):2231-4. doi: 10.1128/AAC.00791-09. Epub 2010 Mar 22.
2
Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides.
Antimicrob Agents Chemother. 2000 Mar;44(3):760-2. doi: 10.1128/AAC.44.3.760-762.2000.
3
Antibiotic resistance and the presence of and genes in β-lactamase-producing clinical isolates from a university hospital in Japan.
J Med Microbiol. 2021 Oct;70(10). doi: 10.1099/jmm.0.001448.
4
cfxA expression in oral clinical Capnocytophaga isolates.
Anaerobe. 2015 Oct;35(Pt B):68-71. doi: 10.1016/j.anaerobe.2015.07.005. Epub 2015 Jul 21.
5
Antimicrobial treatment of Capnocytophaga infections.
Int J Antimicrob Agents. 2007 Apr;29(4):367-73. doi: 10.1016/j.ijantimicag.2006.10.005. Epub 2007 Jan 23.
6
In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.
Antimicrob Agents Chemother. 2000 Nov;44(11):3186-8. doi: 10.1128/AAC.44.11.3186-3188.2000.
7
8
Characterization of CIA-1, an Ambler class A extended-spectrum β-lactamase from Chryseobacterium indologenes.
Antimicrob Agents Chemother. 2012 Jan;56(1):588-90. doi: 10.1128/AAC.05165-11. Epub 2011 Nov 14.
9
Chromosome- and plasmid-encoded beta-lactamases in Capnocytophaga spp.
Antimicrob Agents Chemother. 2005 Sep;49(9):3940-3. doi: 10.1128/AAC.49.9.3940-3943.2005.
10
In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.
Antimicrob Agents Chemother. 1987 Aug;31(8):1283-4. doi: 10.1128/AAC.31.8.1283.
引用本文的文献
1
Antimicrobial Resistance and Comparative Genomic Analysis of subsp. Isolated from Raw Milk.
Antibiotics (Basel). 2022 May 12;11(5):648. doi: 10.3390/antibiotics11050648.
2
In Silico Analysis of Extended-Spectrum β-Lactamases in Bacteria.
Antibiotics (Basel). 2021 Jul 4;10(7):812. doi: 10.3390/antibiotics10070812.
3
The Brief Case: Capnocytophaga sputigena Bacteremia in a 94-Year-Old Male with Type 2 Diabetes Mellitus, Pancytopenia, and Bronchopneumonia.
J Clin Microbiol. 2021 Jun 18;59(7):e0247220. doi: 10.1128/JCM.02472-20.
4
Capnocytophaga sputigena bloodstream infection in hematopoietic stem cell transplantations: two cases report and review of the literature.
Rev Inst Med Trop Sao Paulo. 2020;62:e48. doi: 10.1590/s1678-9946202062048. Epub 2020 Jul 13.
5
Genomic analysis reveals the presence of a class D beta-lactamase with broad substrate specificity in animal bite associated Capnocytophaga species.
Eur J Clin Microbiol Infect Dis. 2017 Apr;36(4):657-662. doi: 10.1007/s10096-016-2842-2. Epub 2016 Dec 1.
6
A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.
Clin Microbiol Rev. 2016 Jan;29(1):29-57. doi: 10.1128/CMR.00019-15.
7
De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD007934. doi: 10.1002/14651858.CD007934.pub3.
8
Characterization of CIA-1, an Ambler class A extended-spectrum β-lactamase from Chryseobacterium indologenes.
Antimicrob Agents Chemother. 2012 Jan;56(1):588-90. doi: 10.1128/AAC.05165-11. Epub 2011 Nov 14.
本文引用的文献
1
2
Antimicrobial treatment of Capnocytophaga infections.
Int J Antimicrob Agents. 2007 Apr;29(4):367-73. doi: 10.1016/j.ijantimicag.2006.10.005. Epub 2007 Jan 23.
3
Chromosome- and plasmid-encoded beta-lactamases in Capnocytophaga spp.
Antimicrob Agents Chemother. 2005 Sep;49(9):3940-3. doi: 10.1128/AAC.49.9.3940-3943.2005.
4
Cloning and biochemical characterization of a class A beta-lactamase from Prevotella intermedia.
Antimicrob Agents Chemother. 2001 Aug;45(8):2386-9. doi: 10.1128/AAC.45.8.2386-2389.2001.
5
The high resolution crystal structure for class A beta-lactamase PER-1 reveals the bases for its increase in breadth of activity.
J Biol Chem. 2000 Sep 8;275(36):28075-82. doi: 10.1074/jbc.M003802200.
6
TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.
Antimicrob Agents Chemother. 2000 Apr;44(4):997-1003. doi: 10.1128/AAC.44.4.997-1003.2000.
7
Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum.
Antimicrob Agents Chemother. 2000 Jan;44(1):1-9. doi: 10.1128/AAC.44.1.1-9.2000.
8
Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases.
Antimicrob Agents Chemother. 1999 Sep;43(9):2193-9. doi: 10.1128/AAC.43.9.2193.
9
Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene.
Antimicrob Agents Chemother. 1999 Mar;43(3):573-81. doi: 10.1128/AAC.43.3.573.
10
Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase.
Antimicrob Agents Chemother. 1996 Mar;40(3):616-20. doi: 10.1128/AAC.40.3.616.
Zotero 插件